Literature DB >> 16100134

Causes and timing of death in patients with ARDS.

Renee D Stapleton1, Bennet M Wang, Leonard D Hudson, Gordon D Rubenfeld, Ellen S Caldwell, Kenneth P Steinberg.   

Abstract

BACKGROUND: Since the early 1980s, case fatality of patients with ARDS has decreased, and explanations are unclear. DESIGN AND METHODS: Using identical definitions of ARDS and organ failure, we analyzed consecutive cohorts of patients meeting syndrome criteria at our institution in 1982 (n = 46), 1990 (n = 112), 1994 (n = 99), and 1998 (n = 205) to determine causes and timing of death.
RESULTS: Overall case fatality has decreased from 68% in 1981-1982 to a low of 29% in 1996, plateauing since the mid-1990s (p = 0.001 for trend). Sepsis syndrome with multiple organ failure remains the most common cause of death (30 to 50%), while respiratory failure causes a small percentage (13 to 19%) of deaths. The distribution of causes of death has not changed over time. There was no change in the timing of death during the study periods: 26 to 44% of deaths occurred early (< 72 h after ARDS onset), and 56 to 74% occurred late (> 72 h after ARDS onset). However, the increased survival over the past 2 decades is entirely accounted for by patients who present with trauma and other risk factors for their ARDS, while survival for those patients whose risk factor is sepsis has not changed. Additionally, withdrawal of life support in these patients is now occurring at our institution significantly more frequently than in the past, and median time until death has decreased in patients who have support withdrawn.
CONCLUSIONS: While these results do not explain the overall case fatality decline in ARDS, they do indicate that sepsis syndrome remains the leading cause of death and suggest that future therapies to improve survival be targeted at reducing the complications of sepsis.

Entities:  

Mesh:

Year:  2005        PMID: 16100134     DOI: 10.1378/chest.128.2.525

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  135 in total

Review 1.  Partial liquid ventilation for preventing death and morbidity in adults with acute lung injury and acute respiratory distress syndrome.

Authors:  Imelda M Galvin; Andrew Steel; Ruxandra Pinto; Niall D Ferguson; Mark W Davies
Journal:  Cochrane Database Syst Rev       Date:  2013-07-23

2.  Angiotensin-converting enzyme insertion/deletion polymorphism is associated with severe hypoxemia in pediatric ARDS.

Authors:  Pablo Cruces; Franco Díaz; Alonso Puga; Benjamín Erranz; Alejandro Donoso; Cristóbal Carvajal; Jan Wilhelm; Gabriela M Repetto
Journal:  Intensive Care Med       Date:  2011-10-18       Impact factor: 17.440

Review 3.  Targeting caspase-1 in sepsis: a novel approach to an old problem.

Authors:  Gustavo Matute-Bello
Journal:  Intensive Care Med       Date:  2007-03-24       Impact factor: 17.440

4.  Ventilator-induced lung injury: another sign of aging?

Authors:  Joan R Badia; Niall D Ferguson
Journal:  Intensive Care Med       Date:  2008-01-05       Impact factor: 17.440

Review 5.  Effect of mechanical ventilation in the prone position on clinical outcomes in patients with acute hypoxemic respiratory failure: a systematic review and meta-analysis.

Authors:  Sachin Sud; Maneesh Sud; Jan O Friedrich; Neill K J Adhikari
Journal:  CMAJ       Date:  2008-04-22       Impact factor: 8.262

6.  Resolving lung injury: a new role for Tregs in controlling the innate immune response.

Authors:  Anthony Pietropaoli; Steve N Georas
Journal:  J Clin Invest       Date:  2009-09-21       Impact factor: 14.808

7.  Derivation and diagnostic accuracy of the surgical lung injury prediction model.

Authors:  Daryl J Kor; David O Warner; Anas Alsara; Evans R Fernández-Pérez; Michael Malinchoc; Rahul Kashyap; Guangxi Li; Ognjen Gajic
Journal:  Anesthesiology       Date:  2011-07       Impact factor: 7.892

8.  A prospective cohort study of ALI/ARDS in the Tohoku district of Japan (second report).

Authors:  Shigeatsu Endo; Shigehiro Shibata; Nobuhiro Sato; Eiji Hashiba; Kimitaka Tajimi; Koji Saito; Kaneyuki Kawamae; Masaki Nakane; Masahiro Murakawa
Journal:  J Anesth       Date:  2010-03-27       Impact factor: 2.078

Review 9.  Enteral omega-3 fatty acid supplementation in adult patients with acute respiratory distress syndrome: a systematic review of randomized controlled trials with meta-analysis and trial sequential analysis.

Authors:  Daojun Zhu; Yi Zhang; Shuo Li; Lu Gan; Huaizhi Feng; Wei Nie
Journal:  Intensive Care Med       Date:  2014-02-21       Impact factor: 17.440

10.  Statin administration did not influence the progression of lung injury or associated organ failures in a cohort of patients with acute lung injury.

Authors:  Daryl J Kor; Remzi Iscimen; Murat Yilmaz; Michael J Brown; Daniel R Brown; Ognjen Gajic
Journal:  Intensive Care Med       Date:  2009-01-31       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.